# Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off

> **NCT00391898** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 95 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Levodopa/carbidopa/entacapone
- **DRUG:** Levodopa/carbidopa

## Key facts

- **NCT ID:** NCT00391898
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2011-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00391898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00391898, "Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00391898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*